Items tagged with Access
Mozambique: Over 3,000 patients under new TB combined preventive therapy (post)
Maputo — 3,413 patients across Mozambique are undertaking the new tuberculosis preventive therapy, coupling strong doses of isoniazid (H) and rifapentine (P), to prevent simple and non-contagious cases from worsening and increasing the number of infected people.
Medicines Patent Pool secures its first licence on promising long-acting technologies for malaria, TB, and hepatitis C (post)
Geneva, 21 September 2021 – The Medicines Patent Pool (MPP) today announced that it has signed a licence agreement with Tandem Nano Ltd (TNL), the University of Liverpool (UoL) start-up focused on the development of its proprietary long-acting nanosystems platform technology. The non-exclusive, worldwide licence covers the patents and expertise of promising long-acting injectable technologies (LAIs) that could be applied in three disease areas with a high prevalence in low- and middle-income countries (LMICs): malaria, tuberculosis (TB), and hepatitis C (HCV). The candidate LAIs, currently developed by the Centre of Excellence for Long-acting Therapeutics (CELT) based at UoL, could provide optimal doses of medicines for malaria chemoprophylaxis, TB prevention, and HCV cure. The research teams are designing medicines to be delivered through a single injection to achieve the desired effect on the pathogens over prolonged periods, suppressing the need for daily oral pills, among many other advantages at the individual and the community levels.
The Lancet Commission on diagnostics: transforming access to diagnostics (post)
Executive summary
A survivor’s take: Why India must ensure a shorter oral regimen to treat drug-resistant TB (post)
Despite the emergence of new medicines to treat the disease, the country’s existing health system offers little help in reducing the suffering of patients.
Global Fund Observer special edition on Ukraine: 31 March 2022 (post)
Aidspan published a special issue of the Global Fund Observer, covering aspects of the Ukrainian-Russian conflict and its impact, both domestic and beyond. It particularly focuses on maintaining essential live-saving services for HIV and TB.
Webinar: From evidence to action: Community-led monitoring for access to TB screening and diagnostic testing (post)
Treatment Action Group and the Coalition of Women Living with HIV and AIDS (COWLHA) will host a webinar on 4 May 2022 explaining how community-led monitoring can be used to generate evidence for advocacy to improve the availability, accessibility, acceptability, and quality of TB screening and diagnostic services.
TB patients in Ukraine at risk, some refugee groups to be tested (post)
Russia’s invasion of Ukraine has put tuberculosis (TB) patients inside the country at high risk due to the lack of access to treatment, while countries receiving refugees have been advised to screen and test certain groups.
Expert: Alarming increase in TB deaths emerging in COVID’s wake (post)
Worldwide reporting of TB cases declined during the pandemic due to lockdowns, social distancing and COVID’s disruption of the healthcare system. Now, TB experts are bracing for a surge of the disease, which, due to improved diagnostics and treatments, had been targeted for global control within 15 years.
Canada: Apologies and promises are not enough to end TB in the North (post)
To finally end tuberculosis in Indigenous communities, the federal government needs to take lessons from the Global South and make a major investment.
Webinar: From evidence to action: Community-led monitoring for access to TB screening and diagnostic testing - materials now available online (post)
On 4 May 2022, Treatment Action Group (TAG) and the Coalition of Women Living with HIV and AIDS (COWLHA) hosted a webinar on how community-led monitoring can be used to generate evidence for advocacy to improve the availability, accessibility, acceptability, and quality of TB screening and diagnostic services.
Page 46 of 83 · Total posts: 0
←First 45 46 47 Last→